Drug-Eluting Stents in Preclinical Studies
- 1 October 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (14) , 1867-1873
- https://doi.org/10.1161/01.cir.0000033485.20594.6f
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Rapamycin eluting stent: the onset of a new era in interventional cardiologyHeart, 2002
- Pressure rinsing of coronary stents immediately before implantation reduces inflammation and neointimal hyperplasiaJournal of the American College of Cardiology, 2001
- A comparison of four stent designs on arterial injury, cellular proliferation, neointima formation, and arterial dimensions in an experimental porcine modelCatheterization and Cardiovascular Interventions, 2001
- ?Metaling? with new stent designsCatheterization and Cardiovascular Interventions, 2001
- Local drug delivery: an emerging approach in the treatment of restenosisVascular Medicine, 2000
- Pathobiologic Responses to Stenting 11Supported in part by grants from the National Institutes of Health (GM/HL49039 and HL03104), the Burroughs Wellcome Fund for Experimental Therapeutics, Durham, North Carolina, and the Whitaker Foundation, Rosslyn, Virginia.The American Journal of Cardiology, 1998
- Intracoronary stentsBMJ, 1996
- Self expanding stents for the management of aorto-ostial stenoses in saphenous vein bypass grafts.Heart, 1994
- Polymeric stenting in the porcine coronary artery model: Differential outcome of exogenous fibrin sleeves versus polyurethane-coated stentsJournal of the American College of Cardiology, 1994
- Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine modelJournal of the American College of Cardiology, 1992